Select Medical Holdings (SEM) Net Margin (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Net Margin data on file, last reported at 4.49% in Q1 2026.

• Net Margin for Q1 2026 came in at 4.49%, up 2796.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 16.18% (down 634.0% YoY), and the FY2025 annual result was 5.71%, down 268.0% from the prior year.
• Net Margin grew to 4.49% in Q1 2026 per SEM's latest filing, from 22.29% in the prior quarter.
• Over five years, Net Margin peaked at 263.4% in Q4 2022 and troughed at 24.17% in Q2 2025.
• A 5-year average of 9.95% and a median of 3.5% in 2022 frame the typical range for Net Margin.
• The sharpest annual moves came in 2022 and 2023: Net Margin soared 27299 bps in 2022, then sank 28211 bps in 2023.
• A 5-year view of Net Margin shows it stood at 263.4% in 2022, then slumped by 107 bps to 18.71% in 2023, then fell by 19 bps to 22.2% in 2024, then fell by 0 bps to 22.29% in 2025, then surged by 120 bps to 4.49% in 2026.
• Business Quant data shows SEM's Net Margin at 4.49% in Q1 2026, 22.29% in Q4 2025, and 23.61% in Q3 2025.